tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

NRIX Stock Latest News

Nurix Therapeutics upgraded to Overweight from Equal Weight at Morgan Stanley
The FlyNurix Therapeutics upgraded to Overweight from Equal Weight at Morgan Stanley
1d ago
NRIX
Nurix Therapeutics Advances Study for NX-5948 in CLL and SLL Patients
PremiumCompany Announcements
Nurix Therapeutics Advances Study for NX-5948 in CLL and SLL Patients
23d ago
NRIX
HOOD, IBTA, IRDM: Cathie Wood Buys the Dip in Robinhood, Sells Ibotta and Iridium Stocks
PremiumMarket News
HOOD, IBTA, IRDM: Cathie Wood Buys the Dip in Robinhood, Sells Ibotta and Iridium Stocks
28d ago
ARKF
Cathie Wood Capitalizes the Surge in Iridium and Biotech Stocks
PremiumMarket News
Cathie Wood Capitalizes the Surge in Iridium and Biotech Stocks
29d ago
TER
ADPT
Nurix Therapeutics price target raised to $30 from $24 at Mizuho
PremiumThe Fly
Nurix Therapeutics price target raised to $30 from $24 at Mizuho
1M ago
ONC
NRIX
Nurix Therapeutics price target raised to $31 from $28 at H.C. Wainwright
PremiumThe FlyNurix Therapeutics price target raised to $31 from $28 at H.C. Wainwright
1M ago
NRIX
Balanced Outlook on Nurix Therapeutics: Promising Developments Amid Uncertainties
Premium
Ratings
Balanced Outlook on Nurix Therapeutics: Promising Developments Amid Uncertainties
1M ago
NRIX
Nurix Therapeutics price target raised to $30 from $27 at BTIG
Premium
The Fly
Nurix Therapeutics price target raised to $30 from $27 at BTIG
1M ago
NRIX
Nurix Therapeutics Reports Promising Data at Hematology Meeting
PremiumCompany Announcements
Nurix Therapeutics Reports Promising Data at Hematology Meeting
1M ago
8K
NRIX
Nurix Therapeutics presents data from Phase 1 trial of bexobrutideg
PremiumThe Fly
Nurix Therapeutics presents data from Phase 1 trial of bexobrutideg
1M ago
NRIX
Nurix presents new clinical data from Phase 1a/1b NX-5948-301 study
PremiumThe Fly
Nurix presents new clinical data from Phase 1a/1b NX-5948-301 study
1M ago
NRIX
Nurix Therapeutics assumed with a Buy at Truist
PremiumThe Fly
Nurix Therapeutics assumed with a Buy at Truist
2M ago
NRIX
Nurix Therapeutics price target lowered to $22 from $30 at JPMorgan
PremiumThe FlyNurix Therapeutics price target lowered to $22 from $30 at JPMorgan
2M ago
NRIX
Nurix Therapeutics Appoints Roger Dansey to Board
Premium
Company Announcements
Nurix Therapeutics Appoints Roger Dansey to Board
2M ago
8K
NRIX
Nurix Therapeutics appoints Dansey to board of directors
Premium
The Fly
Nurix Therapeutics appoints Dansey to board of directors
2M ago
PFE
NRIX
Nurix Therapeutics announces presentation of new data on NX-1607
PremiumThe Fly
Nurix Therapeutics announces presentation of new data on NX-1607
2M ago
NRIX
Promising Data from Nurix Therapeutics’ Bexobrutideg Supports Buy Rating
PremiumRatings
Promising Data from Nurix Therapeutics’ Bexobrutideg Supports Buy Rating
2M ago
NRIX
Nurix Therapeutics’ Bexodeg: Promising Efficacy and Safety Profile Drive Buy Rating
PremiumRatings
Nurix Therapeutics’ Bexodeg: Promising Efficacy and Safety Profile Drive Buy Rating
2M ago
NRIX
Nurix Therapeutics price target lowered to $28 from $33 at H.C. Wainwright
PremiumThe Fly
Nurix Therapeutics price target lowered to $28 from $33 at H.C. Wainwright
2M ago
NRIX
Nurix Therapeutics’ NX-1607 Study: A Potential Game-Changer in Cancer Treatment
PremiumCompany AnnouncementsNurix Therapeutics’ NX-1607 Study: A Potential Game-Changer in Cancer Treatment
2M ago
NRIX
Nurix Therapeutics Advances NX-5948 Study in B-cell Malignancies
Premium
Company Announcements
Nurix Therapeutics Advances NX-5948 Study in B-cell Malignancies
2M ago
NRIX
Nurix Therapeutics’ NX-2127 Study: A Potential Game-Changer in B-cell Malignancy Treatment
Premium
Company Announcements
Nurix Therapeutics’ NX-2127 Study: A Potential Game-Changer in B-cell Malignancy Treatment
2M ago
NRIX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >